SightfileU.S. market data from official filings

Companies › PASG

PASSAGE BIO INC COM NEW (PASG)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001787297 · EDGAR filings · Updated 2026-07-22

PASSAGE BIO INC COM NEW (PASG) has reported institutional ownership of 55.5%, with 35 institutional managers holding positions valued at $13.8M per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
55.5%
Institutional managers
35
Reported 13F value
$13.8M
Insider activity
19 trans.
$631.7K net buying
Data flags
3 active
from SEC filings

Filings this week (1)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, PASSAGE BIO INC COM NEW has 35 institutional holders and institutional ownership of 55.5%.

Insider activity

Insiders reported 19 transactions (6 buys, 9 sells) across 6 reporting insiders, with a net reported value of $631.7K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-12 (recurring since 2022-03-03) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-01-31 (recurring since 2023-09-01) — source filing. The authoritative details are those stated in the filing itself.
Active material impairment disclosure (8-K Item 2.06), most recently filed 2025-01-10 (recurring since 2024-09-06) — source filing. The authoritative details are those stated in the filing itself.

Related companies

MOLECULAR PARTNERS AG (MOLN) · QT IMAGING HLDGS INC (QTI) · Jasper Therapeutics Inc (JSPR) · EDESA BIOTECH INC COM NEW (EDSA) · POLYPID LTD (PYPD) · PALATIN TECHNOLOGIES INC (PTN)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-22.